The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)

The Rare Disease Clinical Research Network Natural History Study of MNGIE

NCT01694953•Columbia University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)

Locations

United States

Locations (1)

Columbia University

New York, New York, United States

Key Dates

Start Date

February 1, 2013

Primary Completion Date

December 1, 2026

Completion Date

December 1, 2026

Last Updated

April 17, 2025

Contacts

Kris Engelstad, MS

CONTACT

212-305-6834 NAMDC@columbia.edu

Sponsors

Lead Sponsor

Columbia University

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 17, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions